Beacon Topco, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Beacon Topco, Inc. and Clywedog Therapeutics have amended their merger agreement, pushing the closing date to October 31, 2026, while Clywedog announced positive Phase 1b trial results for its diabetes drug, balomenib.